BioNTech Analyst Price Targets

BioNTech SE

BNTXNASDAQ

$102.08

-9.33-8.37%

al cierre: Aug 28, 5:00 PM EST

$102.50

0.420.42%

After hour: Aug 28, 7:02 PM EST

PRO

¿Por qué se mueve?:BioNTech shaes are trading lower after the company announced it will termin...

Wall Street analyst price targets and consensus rating for BioNTech (BNTX).

Price Target Range — 12 Quarters

Analyst Consensus — 17 Analysts

14Buy

3Hold

Consensus RatingBuy# Analysts17Avg. Consensus PT$132Upside to Avg. PT+29.2%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 5, 2026	Citigroup	Geoff Meacham	PT Cut	Buy	$130→$125
Aug 5, 2026	Evercore ISI Group	Cory Kasimov	PT Cut	Outperform	$135→$130
Jul 8, 2026	Morgan Stanley	Terence Flynn	PT Cut	Overweight	$126→$119
May 27, 2026	UBS	David Dai	Upgrade	Neutral→Buy	$117→$135
May 22, 2026	Bernstein	Jeffrey Walch	Initiate	Market Perform	$96
May 6, 2026	Canaccord Genuity	John Newman	PT Cut	Buy	$171→$158
May 6, 2026	Wells Fargo	Mohit Bansal	PT Cut	Overweight	$150→$140
Apr 27, 2026	HC Wainwright & Co.	Robert Burns	Maintained	Buy	$130
Apr 10, 2026	Morgan Stanley	Terence Flynn	PT Raise	Overweight	$125→$126
Mar 31, 2026	HC Wainwright & Co.	Robert Burns	PT Cut	Buy	$140→$130
Mar 11, 2026	Morgan Stanley	Terence Flynn	PT Cut	Overweight	$134→$125
Mar 11, 2026	Canaccord Genuity	John Newman	Maintained	Buy	$171
Mar 11, 2026	Citigroup	Geoff Meacham	PT Cut	Buy	$145→$130
Mar 11, 2026	TD Cowen	Yaron Werber	PT Cut	Hold	$116→$94
Mar 11, 2026	BMO Capital	Etzer Darout	PT Cut	Outperform	$143→$128
Mar 10, 2026	Jefferies	Akash Tewari	PT Cut	Buy	$151→$138
Jan 16, 2026	Goldman Sachs	Asad Haider	Upgrade	Neutral→Buy	$115→$142
Nov 10, 2025	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$136→$140
Nov 6, 2025	UBS	David Dai	PT Raise	Neutral	$115→$117
Oct 23, 2025	JP Morgan	Jessica Fye	PT Cut	Neutral	$121→$120